Related Experiment Video

Updated: Feb 18, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

The Application and Future of Big Database Studies in Cardiology: A Single-Center Experience

Kuang-Tso Lee1,2, Ai-Ling Hour3, Ben-Chang Shia4

  • 1Division of Cardiology, Department of Internal Medicine.

Acta Cardiologica Sinica
|November 24, 2017
PubMed

Insights

High-quality cardiovascular research requires strict experimental design and significant resources. Utilizing robust statistical methods on cardiologic databases offers valuable insights into heart health, despite inherent limitations.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Biostatistics

Background:

  • Medical research quality and techniques have advanced, highlighting the need for stricter experimental design in cardiovascular studies.
  • Ethical and economic constraints often limit the verification of promising research hypotheses.
  • Databases are increasingly recognized for their potential in cardiovascular research.

Purpose of the Study:

  • To explore the utility of databases in addressing complex cardiovascular issues.
  • To emphasize the importance of rigorous statistical methods for data analysis.
  • To acknowledge and address the limitations inherent in database research.

Main Methods:

  • Application of rigorous statistical methods to analyze cardiologic databases.
  • Leveraging database applications for insights into rare cardiovascular diseases, women's heart health, and medication analysis.
  • Focus on combining clinical and regional cardiac features through data analysis.

Main Results:

  • Databases can yield significant information on specialized cardiovascular topics when analyzed rigorously.
  • Statistical analysis of databases enables the study of diverse cardiac features and patient populations.
  • Identified the potential for databases to overcome some limitations of traditional research methods.

Conclusions:

  • Reliable analysis and interpretation of cardiologic databases are crucial for advancing cardiovascular research.
  • Database utilization, coupled with strict statistical methods, can enhance our understanding of cardiovascular problems.
  • Addressing database limitations is essential for maximizing their research value.

Keywords:
Big databaseCardiovascular diseasesNational Health Insurance Research Database (NHIRD)

More Related Videos

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.8K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.4K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
939
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
489
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
605
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
395